Key Walgreen revenue metric sinks 6.2 pct in Nov

Published



A key revenue measurement for Walgreen Co. came in lower than Wall Street expected once again last month, as the introduction of generic drugs continued to squeeze revenue for the nation’s largest drugstore chain.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.